{"id":"https://openalex.org/W1998648170","doi":"https://doi.org/10.1002/phar.1204","title":"Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence\u2010Based Support from the Medical Literature","display_name":"Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence\u2010Based Support from the Medical Literature","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-01","ids":{"openalex":"https://openalex.org/W1998648170","doi":"https://doi.org/10.1002/phar.1204","mag":"1998648170","pmid":"https://pubmed.ncbi.nlm.nih.gov/23456734"},"language":"en","primary_location":{"id":"doi:10.1002/phar.1204","doi":"https://doi.org/10.1002/phar.1204","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1204","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998648170"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044168105","display_name":"Bradley M. Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I82497590","display_name":"Auburn University","ror":"https://ror.org/02v80fc35","country_code":"US","type":"education","lineage":["https://openalex.org/I82497590"]},{"id":"https://openalex.org/I83809506","display_name":"University of South Alabama","ror":"https://ror.org/01s7b5y08","country_code":"US","type":"education","lineage":["https://openalex.org/I83809506"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bradley M. Wright","raw_affiliation_strings":["Auburn University Harrison School of Pharmacy, Mobile, Alabama","Departments of Psychiatry and Blank, University of South Alabama College of Medicine, Mobile, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auburn University Harrison School of Pharmacy, Mobile, Alabama","institution_ids":["https://openalex.org/I82497590"]},{"raw_affiliation_string":"Departments of Psychiatry and Blank, University of South Alabama College of Medicine, Mobile, Alabama","institution_ids":["https://openalex.org/I83809506"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074892308","display_name":"Edward H. Eiland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334523821","display_name":"Huntsville Hospital","ror":"https://ror.org/014x3kb31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334523821"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward H. Eiland","raw_affiliation_strings":["Huntsville Hospital Department of Pharmacy, Huntsville Hospital, Huntsville, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsville Hospital Department of Pharmacy, Huntsville Hospital, Huntsville, Alabama","institution_ids":["https://openalex.org/I1334523821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039766067","display_name":"Raymond A. Lorenz","orcid":"https://orcid.org/0000-0002-6241-1003","observed_orcids":["https://orcid.org/0000-0002-6241-1003"]},"institutions":[{"id":"https://openalex.org/I83809506","display_name":"University of South Alabama","ror":"https://ror.org/01s7b5y08","country_code":"US","type":"education","lineage":["https://openalex.org/I83809506"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Lorenz","raw_affiliation_strings":["Department of Psychiatry, AltaPointe Health Systems, Mobile, Alabama","Departments of Psychiatry and Blank, University of South Alabama College of Medicine, Mobile, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, AltaPointe Health Systems, Mobile, Alabama","institution_ids":[]},{"raw_affiliation_string":"Departments of Psychiatry and Blank, University of South Alabama College of Medicine, Mobile, Alabama","institution_ids":["https://openalex.org/I83809506"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044168105"],"corresponding_institution_ids":["https://openalex.org/I82497590","https://openalex.org/I83809506"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.2345,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.74179104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"33","issue":"3","first_page":"344","last_page":"359"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9819999933242798},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9660000205039978},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9869999885559082},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9169999957084656},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.972000002861023},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":1.0},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5509999990463257},{"id":"https://openalex.org/keywords/antidepressant-non-response","display_name":"antidepressant non-response","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8712106943130493},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6329444646835327},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5539782643318176},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4625171422958374},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3728753328323364},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/phar.1204","doi":"https://doi.org/10.1002/phar.1204","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.1204","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:23456734","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23456734","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W169768814","https://openalex.org/W1493214419","https://openalex.org/W1781768774","https://openalex.org/W1929751478","https://openalex.org/W1963845609","https://openalex.org/W1970677460","https://openalex.org/W1980579193","https://openalex.org/W1983900457","https://openalex.org/W1985193354","https://openalex.org/W1992490627","https://openalex.org/W1995984734","https://openalex.org/W2000889437","https://openalex.org/W2002943100","https://openalex.org/W2005310936","https://openalex.org/W2007880575","https://openalex.org/W2010143198","https://openalex.org/W2012655610","https://openalex.org/W2013903216","https://openalex.org/W2018787128","https://openalex.org/W2019727051","https://openalex.org/W2020739757","https://openalex.org/W2024457073","https://openalex.org/W2025525296","https://openalex.org/W2034750014","https://openalex.org/W2035804130","https://openalex.org/W2037486662","https://openalex.org/W2055629924","https://openalex.org/W2059557569","https://openalex.org/W2061360013","https://openalex.org/W2064002445","https://openalex.org/W2065791141","https://openalex.org/W2068927187","https://openalex.org/W2070007822","https://openalex.org/W2078154303","https://openalex.org/W2078402908","https://openalex.org/W2088147965","https://openalex.org/W2089788988","https://openalex.org/W2092430566","https://openalex.org/W2095109387","https://openalex.org/W2098750661","https://openalex.org/W2104518967","https://openalex.org/W2104965135","https://openalex.org/W2109163290","https://openalex.org/W2114693958","https://openalex.org/W2116794049","https://openalex.org/W2119285905","https://openalex.org/W2119334135","https://openalex.org/W2122016047","https://openalex.org/W2123778879","https://openalex.org/W2125094332","https://openalex.org/W2125522266","https://openalex.org/W2139990448","https://openalex.org/W2140787893","https://openalex.org/W2143247032","https://openalex.org/W2170273380","https://openalex.org/W2319197667","https://openalex.org/W2399110179","https://openalex.org/W4229494485","https://openalex.org/W4232541108","https://openalex.org/W4255396331"],"related_works":["https://openalex.org/W2036187623","https://openalex.org/W2064070148","https://openalex.org/W2147860479","https://openalex.org/W2011467143","https://openalex.org/W2035320051","https://openalex.org/W4414180668","https://openalex.org/W2807143852","https://openalex.org/W4243455736","https://openalex.org/W2082597503"],"abstract_inverted_index":{"Major":[0],"depressive":[1],"disorder":[2],"(MDD)":[3],"is":[4,23,260,264],"a":[5,29,34,40,68,74,92],"chronic":[6],"mental":[7],"illness":[8],"that":[9],"affects":[10],"an":[11,257],"estimated":[12],"5-26%":[13],"of":[14,61,97,110,122,140,162,184],"adults":[15],"at":[16,250],"some":[17,247],"time":[18],"in":[19,143,170,188,236],"their":[20,239],"lives.":[21],"Treatment":[22],"often":[24],"started":[25],"as":[26,33,233],"pharmacotherapy":[27,52],"using":[28,178],"single":[30],"drug":[31],"such":[32],"selective":[35],"serotonin":[36],"reuptake":[37],"inhibitor.":[38],"If":[39,269],"patient":[41],"fails":[42],"to":[43,46,56,73,151,246],"respond":[44],"adequately":[45],"the":[47,57,62,78,104,138],"initial":[48,258],"antidepressant,":[49],"typically":[50],"three":[51,198],"options":[53],"are":[54,272],"available":[55],"practitioner.":[58],"The":[59,119,146,227],"dose":[60],"current":[63,79],"therapy":[64,235],"can":[65,70,81],"be":[66,71,82,231,244,278,284],"maximized,":[67],"change":[69],"made":[72],"different":[75],"drug,":[76],"or":[77,113,167],"regimen":[80],"augmented":[83],"with":[84,116,266],"another":[85],"drug.":[86],"Atypical":[87],"antipsychotics":[88,142,180,229,271],"have":[89],"recently":[90],"become":[91],"major":[93],"focus":[94],"for":[95,106,128,181,194],"augmentation":[96,182,263],"traditional":[98],"antidepressant":[99,259],"therapy.":[100],"This":[101],"review":[102],"summarizes":[103],"evidence":[105],"efficacy":[107,276],"and":[108,156,172,223,275,281],"safety":[109,274],"augmenting":[111],"treatment-refractory":[112],"treatment-resistant":[114,144],"depression":[115,185],"atypical":[117,141,179,228,270],"antipsychotics.":[118],"National":[120],"Library":[121],"Medicine's":[123],"MEDLINE":[124],"database":[125],"was":[126,149],"searched":[127],"all":[129],"English-language":[130],"articles":[131],"published":[132],"from":[133],"January":[134],"1966-December":[135],"2011":[136],"describing":[137],"use":[139],"depression.":[145],"literature":[147],"retrieved":[148],"limited":[150],"case":[152,202,209],"series,":[153],"open-label":[154],"trials,":[155],"randomized":[157],"controlled":[158],"trials":[159],"(RCT).":[160],"Studies":[161],"bipolar":[163],"depression,":[164,166],"psychotic":[165],"studies":[168,177],"conducted":[169],"children":[171],"adolescents":[173],"were":[174,186,192],"excluded.":[175],"Thirty-five":[176],"treatment":[183,254],"included":[187],"this":[189],"analysis.":[190],"Trials":[191],"identified":[193],"aripiprazole":[195],"(six":[196],"open-label;":[197,215,220],"RCT),":[199,212,217,222],"clozapine":[200],"(one":[201],"series),":[203],"olanzapine":[204],"(three":[205],"open-label,":[206],"including":[207],"two":[208],"series;":[210],"four":[211],"quetiapine":[213],"(four":[214],"five":[216,221],"risperidone":[218],"(two":[219,225],"ziprasidone":[224],"open-label).":[226],"may":[230,243],"effective":[232],"adjunctive":[234],"MDD;":[237],"however,":[238],"adverse":[240],"effect":[241],"profile":[242],"unfavorable":[245],"patients.":[248],"Trying":[249],"least":[251],"one":[252],"alternative":[253],"strategy":[255],"after":[256],"indicated":[261],"before":[262],"implemented":[265],"these":[267],"agents.":[268],"used,":[273],"should":[277,283],"frequently":[279],"reassessed":[280],"dosage":[282],"individualized.":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998648170","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
